Page last updated: 2024-10-18

dihydroxyphenylalanine and Retinitis Pigmentosa

dihydroxyphenylalanine has been researched along with Retinitis Pigmentosa in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Retinitis Pigmentosa: Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OYA, T1
KUNO, Y1
Matsushita, K1

Trials

1 trial available for dihydroxyphenylalanine and Retinitis Pigmentosa

ArticleYear
[Fundamental study on the treatment of retinitis pigmentosa].
    Nippon Ganka Gakkai zasshi, 1969, Volume: 73, Issue:11

    Topics: Adolescent; Adult; Aged; Amino Acids; Animals; Antidotes; Anura; Clinical Trials as Topic; Dihydroxy

1969

Other Studies

1 other study available for dihydroxyphenylalanine and Retinitis Pigmentosa

ArticleYear
[Etiology and treatment of retinitis pigmentosa. XI. Clinical results with alpha-methyl-DOPA].
    Rinsho ganka. Japanese journal of clinical ophthalmology, 1963, Volume: 17

    Topics: Dihydroxyphenylalanine; Humans; Methyldopa; Retinitis Pigmentosa

1963